Top Markets
Coin of the day
Liminatus Pharma, Inc. Class A Common Stock Liminatus Pharma, Inc. Class A Common Stock

Liminatus Pharma, Inc. Class A Common Stock

LIMN
Rangering i aksjer #32712
Liminatus Pharma, Inc. is an immuno-oncology firm, currently in its clinical... Liminatus Pharma, Inc. is an immuno-oncology firm, currently in its clinical development phase, dedicated to pioneering new treatments for cancer. The company's headquarters are located in La Palma, California.
Aksjekurs
$0.1363
Markedsverdi
$9.15M
Endring (1 dag)
-2.64%
Endring (1 år)
-96.59%
Land
US
Handel Liminatus Pharma, Inc. Class A Common Stock (LIMN)

Kategori

Pris LIMN pris med markedsverdi på B
Liminatus Pharma, Inc. Class A Common Stock Liminatus Pharma, Inc. Class A Common Stock
LIMN
$0.1363
Markedsverdi av Liminatus Pharma, Inc. Class A Common Stock(LIMN)
Markedsverdi: $9.15M
Per August 2026 har Liminatus Pharma, Inc. Class A Common Stock en markedsverdi på $9.15M. Dette gjør Liminatus Pharma, Inc. Class A Common Stock til det 32712th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Liminatus Pharma, Inc. Class A Common Stock fra 2025 til 2026
LIMN sammenlignet med topp 5 mest populære stocks
Pris på LIMN Eiendel B Markedsverdi for B Resultater
Liminatus Pharma, Inc. Class A Common Stock Liminatus Pharma, Inc. Class A Common Stock
$81,382.99 $9.15M
$5.466T +59,708,623.79%
Liminatus Pharma, Inc. Class A Common Stock Liminatus Pharma, Inc. Class A Common Stock
$66,652.62 $9.15M
$4.476T +48,901,308.03%
Liminatus Pharma, Inc. Class A Common Stock Liminatus Pharma, Inc. Class A Common Stock
$61,691.11 $9.15M
$4.143T +45,261,169.29%
Liminatus Pharma, Inc. Class A Common Stock Liminatus Pharma, Inc. Class A Common Stock
$53,038.87 $9.15M
$3.562T +38,913,234.13%
Liminatus Pharma, Inc. Class A Common Stock Liminatus Pharma, Inc. Class A Common Stock
$41,601.21 $9.15M
$2.794T +30,521,699.05%